Literature DB >> 6364429

Complement, viruses, and virus-infected cells.

N R Cooper, G R Nemerow.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6364429      PMCID： PMC7087538          DOI： 10.1007/bf02116278

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  62 in total

1.  Antibody-independent neutralization of vesicular stomatitis virus by human complement. I. Complement requirements.

Authors:  B J Mills; N R Cooper
Journal:  J Immunol       Date:  1978-10       Impact factor: 5.422

2.  Antibody-induced redistribution of measles virus antigens on the cell surface.

Authors:  B S Joseph; M B Oldstone
Journal:  J Immunol       Date:  1974-10       Impact factor: 5.422

3.  Immune virolysis: effect of antibody and complement on C-type RNA virus.

Authors:  S Oroszlan; R V Gilden
Journal:  Science       Date:  1970-06-19       Impact factor: 47.728

4.  Inactivation of lysis of oncornaviruses by human serum.

Authors:  R M Welsh; F C Jensen; N R Cooper; M B Oldstone
Journal:  Virology       Date:  1976-10-15       Impact factor: 3.616

5.  Antibody-induced capping of measles virus antigens on plasma membrane studied by electron microscopy.

Authors:  P W Lampert; B S Joseph; M B Oldstone
Journal:  J Virol       Date:  1975-05       Impact factor: 5.103

6.  Neutralization of influenza virus by normal human sera: mechanisms involving antibody and complement.

Authors:  D P Beebe; R D Schreiber; N R Cooper
Journal:  J Immunol       Date:  1983-03       Impact factor: 5.422

7.  Alterations in expression of measles virus polypeptides by antibody: molecular events in antibody-induced antigenic modulation.

Authors:  R S Fujinami; M B Oldstone
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

8.  Antibody-independent neutralization of vesicular stomatitis virus by human complement. II. Formation of VSV-lipoprotein complexes in human serum and complement-dependent viral lysis.

Authors:  B J Mills; D P Beebe; N R Cooper
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

9.  Neutralization of vesicular stomatitis virus (VSV) by human complement requires a natural IgM antibody present in human serum.

Authors:  D P Beebe; N R Cooper
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

10.  The formation and fate of virus antigen-antibody complexes.

Authors:  L H Perrin; M B Oldstone
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422
View more
  19 in total

Review 1.  Target recognition failure by the nonspecific defense system: surface constituents of pathogens interfere with the alternative pathway of complement activation.

Authors:  R D Horstmann
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

2.  Retrovirus-induced feline pure red cell aplasia. Hematopoietic progenitors are infected with feline leukemia virus and erythroid burst-forming cells are uniquely sensitive to heterologous complement.

Authors:  J L Abkowitz; R D Holly; C K Grant
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

3.  Coagulation factor defends adenovirus from immune attack.

Authors:  Glen R Nemerow
Journal:  Nat Med       Date:  2013-04       Impact factor: 53.440

4.  Complement subcomponent C1q secreted by cultured human monocytes has subunit structure identical with that of serum C1q.

Authors:  A J Tenner; D B Volkin
Journal:  Biochem J       Date:  1986-01-15       Impact factor: 3.857

5.  Hypothesis: selective ineffective humoral immune responsiveness as a possible cause of certain chronic inflammatory disorders. Theoretical considerations and rationale for treatment.

Authors:  A Hässig; H Cottier
Journal:  Klin Wochenschr       Date:  1986-05-02

6.  Species selective interaction of Alphaherpesvirinae with the "unspecific" immune system of the host.

Authors:  H P Huemer; C Larcher; S van Drunen Littel-van den Hurk; L A Babiuk
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

7.  Disabling complement regulatory activities of vaccinia virus complement control protein reduces vaccinia virus pathogenicity.

Authors:  John Bernet; Muzammil Ahmad; Jayati Mullick; Yogesh Panse; Akhilesh K Singh; Pradeep B Parab; Arvind Sahu
Journal:  Vaccine       Date:  2011-07-29       Impact factor: 4.169

Review 8.  Idiopathic membranoproliferative glomerulonephritis in childhood.

Authors:  C D West
Journal:  Pediatr Nephrol       Date:  1992-01       Impact factor: 3.714

9.  Membrane-bound complement regulatory activity is decreased on vaccinia virus-infected cells.

Authors:  L Baranyi; N Okada; K Baranji; H Takizawa; H Okada
Journal:  Clin Exp Immunol       Date:  1994-10       Impact factor: 4.330

10.  Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope.

Authors:  A Vanderplasschen; E Mathew; M Hollinshead; R B Sim; G L Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.